Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients

By Dobnig H.   Hofbauer L.   Viereck V.   Obermayer-Pietsch B.   Fahrleitner-Pammer A.  

Osteoporosis International, Vol. 17, Iss. 5, 2006-05 ,pp. : 693-703

Springer Publishing Company

Access to resources Recommend Favorite

Prescribed vitamin D and calcium preparations in patients treated with bone remodelling agents in primary care: a report of a pilot study

By Bayly J. R.   Hollands R. D.   Riordan-Jones S. E.   Yemm S. J.   Brough-Williams I.   Thatcher M.   Woodman N. M.   Dixon T.  

Current Medical Research and Opinion, Vol. 22, Iss. 1, 2006-01 ,pp. : 131-137

Informa Healthcare

Access to resources Recommend Favorite

Bisphosphonate-Associated Osteonecrosis of the Jaw in Patients with Multiple Myeloma and Breast Cancer

By  

Acta Haematologica, Vol. 117, Iss. 3, 2006-12 ,pp. : 181-187

Karger

Access to resources Recommend Favorite

Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 598-601

John Wiley & Sons Inc

Access to resources Recommend Favorite

Characteristics of Medically and Surgically Treated Empyema Patients: A Retrospective Cohort Study

By  

Respiration, Vol. 86, Iss. 4, 2013-08 ,pp. : 288-294

Karger

Access to resources Recommend Favorite